Combination of [(177)Lu]Lu-DOTA-TATE Targeted Radionuclide Therapy and Photothermal Therapy as a Promising Approach for Cancer Treatment: In Vivo Studies in a Human Xenograft Mouse Model

Peptide receptor radionuclide therapy (PRRT) relies on α- and β-emitting radionuclides bound to a peptide that commonly targets somatostatin receptors (SSTRs) for the localized killing of tumors through ionizing radiation. A Lutetium-177 ((177)Lu)-based probe linked to the somatostatin analog octreo...

Descripción completa

Detalles Bibliográficos
Autores principales: Simón, Marina, Jørgensen, Jesper Tranekjær, Khare, Harshvardhan A., Christensen, Camilla, Nielsen, Carsten Haagen, Kjaer, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227845/
https://www.ncbi.nlm.nih.gov/pubmed/35745856
http://dx.doi.org/10.3390/pharmaceutics14061284

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227845/
https://www.ncbi.nlm.nih.gov/pubmed/35745856
http://dx.doi.org/10.3390/pharmaceutics14061284

Ejemplares similares